News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 hours. L.A. McKeown November 07, 2025
Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025
Presentation ACC 2025 Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study Presenter: Isabelle Mahé March 29, 2025
Presentation Miami Valves 2025 Something in the Way: An RV in Crisis Presenter: Enrique Soltero Mariscal January 30, 2025
Presentation Miami Valves 2025 A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement Presenter: Lourdes Villarrubia Varela January 30, 2025
Presentation Cardiovascular Interventions 2024 Building Your PERT Team: Designing the Right Team with the Right Technology Presenter: Curtiss T. Stinis November 11, 2024
News Daily News Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE By Michael O'Riordan November 24, 2025
News Daily News Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis By Todd Neale November 21, 2025
News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss By L.A. McKeown November 07, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? By Michael O'Riordan November 05, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2025 By Caitlin E. Cox November 03, 2025